Actelion steps up charm offensive to counter Elliott bid
This article was originally published in Scrip
Executive Summary
With less than two weeks to the 5 May annual general meeting which could ultimately decide the future course of specialty pharma company Actelion, the competing slates are ratcheting up their campaigns.